Description

Gefitinib Tablet 250 mg is a targeted therapy used to treat non-small cell lung cancer (NSCLC). It works by inhibiting the epidermal growth factor receptor (EGFR) pathway, slowing cancer cell growth and improving outcomes for patients with specific gene mutations.